Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Adam Craig

Tracked across 1 events · 7 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026

Sentiment
0
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
X4 Pharmaceuticals announced a positive outcome from its Type C meeting with the United States — Food and Drug Administration regarding the global 4WARD Phase 3 clinical trial for mavorixafor in chronic neutropenia. The FDA…
Impact: Adam Craig is the Executive Chairman of X4 Pharmaceuticals and is quoted in the announcement. His role is to communicate the company's strategy and expectations, but he is not directly impacted by the event.
Sep 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Adam Craig live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.